HMGB1 and neoplasm: However, under chronic high‐dose HMGB1 exposure or specific TLR4 polymorphisms, the HMGB1‐TLR4 signal instead inhibits phagosome‐lysosome fusion, reduces tumor antigen cross‐presentation, and causes failed CD8+ T cell priming.